Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the MOBILIZE-1 Phase 3 clinical trial evaluating the safety, immunogenicity and efficacy of a ...

Children who experience multiple cases of dengue virus develop an army of dengue-fighting T cells, according to a new study led by scientists at La Jolla Institute for Immunology (LJI).

Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.

The Centers for Disease Control and Prevention has issued a health advisory warning of an increase in dengue virus infections this year. Dengue is a viral disease caused by any of the four dengue ...

The Centers for Disease Control and Prevention (CDC) issued an alert on Tuesday advising health care providers and public health authorities about an elevated risk of dengue fever infections in ...